Protracted Effect of the Ultrasound-guided Saphenous Block
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Selinexor and Backbone Treatments of Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Selinexor Treatment of Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia
- Status
- COMPLETED
- Phase
- PHASE3
Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Intra-Articular Dexamethasone to Prevent Post-Traumatic Osteoarthritis: A Pilot Study
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Dexamethasone and Wound Healing After Thyroid Surgery
- Status
- COMPLETED
- Phase
- NA
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Cervical Transforaminal Injection of Steroids Guided by Ultrasound
- Status
- UNKNOWN
- Phase
- NA
Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
- Status
- TERMINATED
- Phase
- PHASE2
Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)
- Status
- COMPLETED
- Phase
- PHASE4
Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
- Status
- UNKNOWN
- Phase
- PHASE2
SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients
- Status
- COMPLETED
- Phase
- PHASE1
E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1